We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
-0.72%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$16.7B
AUM Growth
-$332M
Cap. Flow
-$57.8M
Cap. Flow %
-0.35%
Top 10 Hldgs %
17.41%
Holding
2,287
New
114
Increased
795
Reduced
1,162
Closed
171
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JBSS icon
1151
John B. Sanfilippo & Son
JBSS
$972M
$1.64M 0.01%
20,103
+9,695
+93% +$841K
OHI icon
1152
Omega Healthcare
OHI
$14.7B
$1.64M 0.01%
54,837
-17,849
-25% -$614K
TLK icon
1153
Telkom Indonesia
TLK
$14.9B
$1.64M 0.01%
64,685
+14,567
+29% +$335K
USHY icon
1154
iShares Broad USD High Yield Corporate Bond ETF
USHY
$28.7B
$1.64M 0.01%
39,496
+21,723
+122% +$903K
CHDN icon
1155
Churchill Downs
CHDN
$6.12B
$1.63M 0.01%
13,582
-730
-5% -$74.2K
TTE icon
1156
TotalEnergies
TTE
$190B
$1.63M 0.01%
33,991
+6,625
+24% +$294K
FTI icon
1157
TechnipFMC
FTI
$27.3B
$1.62M 0.01%
215,376
+17,839
+9% +$128K
TRTN
1158
DELISTED
Triton International Limited
TRTN
$1.62M 0.01%
31,076
-2,126
-6% -$110K
GEN icon
1159
Gen Digital
GEN
$17.5B
$1.61M 0.01%
63,748
-28,973
-31% -$754K
MGM icon
1160
MGM Resorts International
MGM
$11.2B
$1.61M 0.01%
37,311
-3,350
-8% -$136K
CATY icon
1161
Cathay General Bancorp
CATY
$4.24B
$1.61M 0.01%
38,886
-13,153
-25% -$513K
SNX icon
1162
TD Synnex
SNX
$20.2B
$1.61M 0.01%
15,439
-9,976
-39% -$1.19M
PODD icon
1163
Insulet
PODD
$9.79B
$1.6M 0.01%
5,646
+687
+14% +$196K
FOLD
1164
DELISTED
Amicus Therapeutics
FOLD
$1.6M 0.01%
167,742
-14,183
-8% -$145K
PNF
1165
DELISTED
PIMCO New York Municipal Income Fund
PNF
$1.6M 0.01%
128,059
+8,758
+7% +$114K
TD icon
1166
Toronto Dominion Bank
TD
$200B
$1.6M 0.01%
24,180
+13,276
+122% +$885K
FLNA
1167
Filana Therapeutics
FLNA
$48.1M
$1.59M 0.01%
+25,697
New +$2.14M
CEV
1168
Eaton Vance California Municipal Income Trust
CEV
$73.6M
$1.59M 0.01%
116,612
-26,777
-19% -$375K
AVT icon
1169
Avnet
AVT
$7.92B
$1.59M 0.01%
42,919
-62,895
-59% -$2.49M
DBL
1170
DoubleLine Opportunistic Credit Fund
DBL
$280M
$1.59M 0.01%
80,436
-644
-0.8% -$12.8K
AFG icon
1171
American Financial Group
AFG
$12.1B
$1.58M 0.01%
12,593
+1,376
+12% +$180K
PNFP icon
1172
Pinnacle Financial Partners Inc
PNFP
$15.8B
$1.58M 0.01%
16,820
-5,959
-26% -$548K
SNY icon
1173
Sanofi
SNY
$104B
$1.58M 0.01%
32,800
-252
-0.8% -$12.8K
VCYT icon
1174
Veracyte
VCYT
$3.8B
$1.58M 0.01%
34,014
-4,418
-11% -$193K
FSD
1175
DELISTED
FIRST TRUST HIGH INCOME LONG/SHORT FUND
FSD
$1.57M 0.01%
98,855
+62,295
+170% +$991K

Similar funds

Guggenheim Capital's Q3 2021 Portfolio in Review

As of Q3 2021, Guggenheim Capital held 2,287 positions worth $16.7B, down 2% from $17B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Guggenheim Capital's Q3 2021 filing shows 114 new, 795 increased, 1,162 reduced and 171 closed positions. Its largest new stake was Logistics Innovation Technologies Corp. Class A Common Stock: 4,000,000 shares worth $38.6M. The largest sale was Alexion Pharmaceuticals, an estimated $41.8M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Guggenheim Capital's largest Q3 2021 buy was Logistics Innovation Technologies Corp. Class A Common Stock: 4,000,000 shares worth $38.6M.
  • Guggenheim Capital added most to iShares Core US Aggregate Bond ETF in Q3 2021, an estimated $50M increase.
  • Guggenheim Capital's biggest Q3 2021 reduction was Matterport, Inc. Class A Common Stock, cutting an estimated $32.4M.
  • Guggenheim Capital fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $41.8M.
  • Guggenheim Capital's ten largest holdings make up 17% of its $16.7B portfolio in Q3 2021.
  • Guggenheim Capital opened 114 new positions and closed 171 in Q3 2021.
  • Guggenheim Capital's portfolio value fell 2% quarter-over-quarter to $16.7B.

Based on Guggenheim Capital's 13F filing for Q3 2021, filed 15 Nov 2021.